secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001193125-26-157126
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics receives Nasdaq delisting notice for equity shortfall; 45 days to submit plan
--------------------------------------------------------------------------------

- Nasdaq notified Alaunos on April 9, 2026, of non-compliance with minimum $2.5M stockholders' equity; 2025 10-K reported $2.153M.
- Company also fails alternative listing standards: market value of listed securities $35M or net income $500K last fiscal year.
- Must submit compliance plan by May 26, 2026; if accepted, Nasdaq may grant up to 180-day extension.
- If plan rejected or extension not achieved, Company may request hearing before Nasdaq hearings panel.
- Trading in TCRT common stock continues pending disclosure and compliance process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526157126/0001193125-26-157126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526157126/tcrt-20260409.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-157126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer